Nε-(1-carboxyethyl)-L-lysine

Nε-(1-carboxyethyl)-L-lysine has been studied in 1 paper since 2023: 1 observational study in people. The newest paper, Aug 8, 2023: “Higher dietary advanced glycation products intake is associated with increased risk of dementia, independent from genetic predisposition”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on nε-(1-carboxyethyl)-L-lysine

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Higher intakes of dietary AGEs including CEL, CML and MG-H1 were associated with a higher risk of dementia”
Higher dietary advanced glycation products intake is associated with increased risk of dementia, independent from genetic predispositionClinical nutrition (Edinburgh, Scotland)2023doi:10.1016/j.clnu.2023.08.006
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Humans1

What is nε-(1-carboxyethyl)-L-lysine linked with?

1

Studies link nε-(1-carboxyethyl)-L-lysine with dementia.

Dementia

upin humans1HR 1.53

1 study
  1. Nε-(1-carboxyethyl)-L-lysine is associated with dementia in humans (Free from dementia at baseline; multivariable-adjusted analysis) (HR 1.53, 95% CI 1.25–1.89).

    “Higher intakes of dietary AGEs including CEL, CML and MG-H1 were associated with a higher risk of dementia”

    HumansFree from dementia at baseline; multivariable-adjusted analysisHighest versus lowest tertile of intakeMedian follow-up of 11.9 yearsn = 93,830

    Higher dietary advanced glycation products intake is associated with increased risk of dementia, independent from genetic predisposition

    Clinical nutrition (Edinburgh, Scotland)

More on Dementia

Latest